Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and ...
Genio also unveiled The Confident Notetaker's Masterclass, an hour-long, tool-agnostic interactive course created by learning experts that teaches participants techniques and strategies to enhance the ...
Zacks Investment Research on MSN
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Nyxoah NYXH recently announced that the CY2026 Hospital Outpatient Prospective Payment System (“HOPPS”) and Ambulatory Surgery Center (“ASC”) Rule has been finalized by the U.S. Centers for Medicare & ...
Assignment to New Technology APC 1580 is positive news for Nyxoah’s U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1 ...
The Genio system is now available in the US for OSA patients who meet eligibility criteria. The Food and Drug Administration (FDA) has approved the Genio ® system for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback